Diabetes, Gestational

ARLINGTON, Va., Oct. 24, 2024 /PRNewswire/ -- Today, the American Diabetes Association® (ADA) and Blue Cross and Blue Shield of Minnesota announced a new endeavor to address disparities in maternal health care delivery, with an emphasis on the impact of gestational diabetes (GDM)—diabetes that occurs during pregnancy. A new professional education series will seek to eliminate provider biases and encourage implementation of the ADA's Standards of Care in Diabetes (Standards of Care) to optimize maternal and infant health outcomes. GDM affects up to 9% of pregnancies in the U.S. and carries health risks for both mothers and children during pregnancy and after birth. Women who are Black, Hispanic, Native American, or Asian, or who are socioeconomically disadvantaged, are far more likely than their more advantaged peers to suffer from GDM and its adverse effects. "Gestational diabetes not only increases the risk of adverse pregnancy outcomes, but also creates a greater risk of developing overt diabetes later in life, damaging both short- and long-term health," said Bukata Hayes, vice president of racial and health equity and chief equity officer at Blue Cross and Blue Shield of Minnesota. "That it more deeply impacts birthers that are Black, Latine, Indigenous, Asian Pacific Islander or are socioeconomically disadvantaged, emphasizes the work we need to do to ensure everyone has access to quality and affordable culturally concordant care." Together, the ADA and Blue Cross and Blue Shield of Minnesota will create a nationally available educational series of webinars and webcasts for health care and allied professionals. The series will focus on: Understanding the root causes of maternal health disparities on women and their children who are residents of marginalized communities. Identifying and eliminating provider bias. The latest clinical guidance from the ADA's Standards of Care. The role of allied professionals and non-traditional community-based resources to provide wrap-around care needed for women and their children to thrive. The series is supported by a $750,000 educational grant from Blue Cross and Blue Shield of Minnesota and offers up to 4.5 continuing education credits. The initial series is expected to launch during American Diabetes Month® in November 2024 through the ADA's Institute of Learning. "Maternal health care teams, including doulas, midwives, and other health care professionals, are at the heart of culturally respectful, effective care delivery. Through this partnership, we're able to offer additional support and the latest evidence-based care recommendations as these teams work to improve health outcomes for those most deeply affected," said Charles "Chuck" Henderson, the ADA's chief executive officer. About the American Diabetes Association The American Diabetes Association (ADA) is the nation's leading voluntary health organization fighting to end diabetes and helping people thrive. For 84 years, the ADA has driven discovery and research to prevent, manage, treat, and ultimately cure diabetes. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we're fighting for them all. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join the fight with us on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). Contact: [email protected] SOURCE American Diabetes Association WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

TUESDAY, Oct. 1, 2024 -- Preconception prediabetes is associated with increased odds of gestational diabetes among adolescents and young adults, according to a study published online Sept. 24 in JAMA Network Open . Katharine J. McCarthy, Ph.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues conducted a retrospective cohort study using linked 2009 to 2017 birth registry, hospital discharge, and New York City Department of Health A1C Registry data for pregnant individuals aged 10 to 24 years. Eligibility criteria were met by 14,302 individuals: 41.0 percent Hispanic, 29.0 percent Black, 18.1 percent White, 10.6 percent Asian, and 1.3 percent other or unknown race and ethnicity. The researchers found that 79.7 and 20.2 percent of participants had normoglycemia and prediabetes, respectively. Compared with those with normoglycemia, those with preconception prediabetes had more than twice the risk for gestational diabetes (adjusted relative risk [aRR], 2.21) after adjusting for prepregnancy characteristics. Small increases in the likelihood of a hypertensive disorder of pregnancy (aRR, 1.18) and preterm delivery (aRR, 1.18) were seen in association with preconception prediabetes. Increases were seen in the risks for cesarean delivery and macrosomia, but they were not statistically significant. For identifying gestational diabetes among adolescents and young adults, the optimal hemoglobin A1c threshold was 5.6 percent. "Given alarming trends in adolescent obesity and diabetes risk and the high prevalence of unplanned pregnancies in adolescence and young adulthood, our results support expanded preconception screening as a mechanism to intervene on excess cardiometabolic risk earlier in the life course," the authors write. Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

FRIDAY, Sept. 27, 2024 -- Casual blood glucose (CBG) testing at 24 to 28 gestational weeks misses about 70 percent of women with gestational diabetes mellitus (GDM), according to a study published online Sept. 18 in the Journal of Diabetes Investigation . Masako Tomimoto, M.D., from the Kobe University Graduate School of Medicine in Japan, and colleagues enrolled 763 pregnant women who underwent the 50-g glucose challenge test (GCT) at 24 to 28 gestational weeks to examine problems in screening for GDM by CBG measurements. The preload blood glucose (0-h BG) on 50-g GCT with CBG was identified, and the relationship between 50-g GCT positivity (1-h BG on 50-g GCT ≥140 mg/dL) and CBG positivity (0-h BG on 50-g GCT ≥100 mg/dL) was examined. The researchers found that of the 240 women with 50-g GCT positivity who underwent the 75-g oral glucose tolerance test, GDM was diagnosed in 98 (40.8 percent). Overall, 71 (71.7 percent) of the 99 women with GDM had 0-h BG <100 mg/dL on 50-g GCT. "Although there have been studies showing that the casual blood glucose test is less sensitive than others, no studies have directly compared the results in the same individuals," Tomimoto said in a statement. "Our study confirmed that this screening method, which is widely used in practice, frequently misses the condition it is meant to detect." Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.